BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 35818587)

  • 1. Methylated Septin 9 as a Promising Biomarker in the Diagnosis and Recurrence Monitoring of Colorectal Cancer.
    Lu P; Zhu X; Song Y; Luo Y; Lin J; Zhang J; Cao Y; Huang Z
    Dis Markers; 2022; 2022():7087885. PubMed ID: 35818587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of circulating methylated Septin9 gene DNA in diagnosis and recurrence monitoring of colorectal cancer in Western China.
    Gao JJ; Wang YW; Li Y; Wang ZL; Feng A; Li N; Hui LY
    Clin Chim Acta; 2022 Dec; 537():118-126. PubMed ID: 36330944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylated Septin9 has moderate diagnostic value in colorectal cancer detection in Chinese population: a multicenter study.
    Lu DC; Zhang QF; Li L; Luo XK; Liang B; Lu YH; Hu BL; Jiang HX
    BMC Gastroenterol; 2022 May; 22(1):232. PubMed ID: 35546391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of serum methylated septin 9 and carcinoembryonic antigen in efficacy evaluation and follow-up monitoring of colorectal cancer.
    Gao H; Zhu ZQ; Wusiman L; Wujieke A; Zhang WB
    Ann Ital Chir; 2023; 94():384-391. PubMed ID: 37794798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic Value of Methylated
    Xie L; Jiang X; Li Q; Sun Z; Quan W; Duan Y; Li D; Chen T
    Front Oncol; 2018; 8():247. PubMed ID: 30013949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylated Septin 9 and Carcinoembryonic Antigen for Serological Diagnosis and Monitoring of Patients with Colorectal Cancer After Surgery.
    Ma ZY; Law WL; Ng EKO; Chan CSY; Lau KS; Cheng YY; Shin VY; Kwong A; Leung WK
    Sci Rep; 2019 Jul; 9(1):10326. PubMed ID: 31316143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylated Septin9 identified patients with colorectal carcinoma and showed higher sensitivity than conventional biomarkers in detecting tumor.
    Leerhoff S; Raem A; Kolbe EW; Schulz L; Borchers K; Köhler T; Winde G; Kirchner C
    Cancer Treat Res Commun; 2023; 36():100748. PubMed ID: 37541105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Value and Clinical Significance of Methylated SEPT9 for Colorectal Cancer: A Meta-Analysis.
    Hu J; Hu B; Gui YC; Tan ZB; Xu JW
    Med Sci Monit; 2019 Aug; 25():5813-5822. PubMed ID: 31378778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The stool
    Zhan Y; Wang S; Yuan Z; Zhao X; Ni K; Xin R; Zhou X; Liu Z; Yin X; Ping H; Liu Y; Wang W; Yan S; Han Q; Zhang X; Zhang Q; Liu Y; Zhang C
    Transl Cancer Res; 2023 Jan; 12(1):65-77. PubMed ID: 36760372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical value of preoperative methylated septin 9 in Chinese colorectal cancer patients.
    Yang X; Xu ZJ; Chen X; Zeng SS; Qian L; Wei J; Peng M; Wang X; Liu WL; Ma HY; Gong ZC; Yan YL
    World J Gastroenterol; 2019 May; 25(17):2099-2109. PubMed ID: 31114136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-Free Circulating Methylated SEPT9 for Noninvasive Diagnosis and Monitoring of Colorectal Cancer.
    Fu B; Yan P; Zhang S; Lu Y; Pan L; Tang W; Chen S; Chen S; Zhang A; Liu W
    Dis Markers; 2018; 2018():6437104. PubMed ID: 29849824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylated septin 9 gene is an important prognostic marker in stage II and stage III colorectal cancer for evaluating local recurrence or distant metastasis after surgery.
    Huang M; He J; Lai W; Liu L; Xu H; Zeng Y; Lan Q; Lin X; Chu Z
    BMC Gastroenterol; 2022 Feb; 22(1):87. PubMed ID: 35227194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma Methylated SEPT9 as a Novel Biomarker for Predicting Liver Metastasis in Colorectal Cancer.
    Yu M; Yang C; Wang S; Shi Y; Wang J; Meng C; Xue L; Chen Z
    Mol Biotechnol; 2023 Aug; ():. PubMed ID: 37608077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of blood mSEPT9 in evaluating tumor burden and disease monitoring in colorectal cancer patients.
    Jiang H; Yu Q; Chen X; Zhang C; Shen J; Shen M; Yang Y; Wang B; Pan B; Guo W
    J Clin Lab Anal; 2021 Nov; 35(11):e24030. PubMed ID: 34591323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The blood mSEPT9 is capable of assessing the surgical therapeutic effect and the prognosis of colorectal cancer.
    Song L; Guo S; Wang J; Peng X; Jia J; Gong Y; Yang B; Xiao W; Dong C; Liu H; Li Y
    Biomark Med; 2018 Sep; 12(9):961-973. PubMed ID: 30043648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between Clinical Utility of CXCL-8 and Clinical Practice Tumor Markers for Colorectal Cancer Diagnosis.
    Huang Z; Li Z; Chen X; Zhu X; Zhang J; Song Y; Cao Y; Lu P
    Biomed Res Int; 2022; 2022():1213968. PubMed ID: 36567905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of
    Sun J; Fei F; Zhang M; Li Y; Zhang X; Zhu S; Zhang S
    BMC Cancer; 2019 May; 19(1):450. PubMed ID: 31088406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating methylated septin 9 nucleic Acid in the plasma of patients with gastrointestinal cancer in the stomach and colon.
    Lee HS; Hwang SM; Kim TS; Kim DW; Park DJ; Kang SB; Kim HH; Park KU
    Transl Oncol; 2013 Jun; 6(3):290-6. PubMed ID: 23730408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Cyr61 as a potential biomarker for diagnosis of colorectal cancer.
    Song YF; Xu ZB; Zhu XJ; Tao X; Liu JL; Gao FL; Wu CL; Song B; Lin Q
    Clin Transl Oncol; 2017 Apr; 19(4):519-524. PubMed ID: 27743169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Clinical Diagnostic and Prognostic Value of Preoperative Serum Carcinoembryonic Antigen, CA19-9, and CA24-2 for Colorectal Cancer.
    Hou S; Jing J; Wang Y; Du L; Tian B; Xu X; Sun T; Shi Y
    Altern Ther Health Med; 2023 Sep; 29(6):192-197. PubMed ID: 37295009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.